-
Oseltamivir treatment of children with influenza A virus infection was associated with the selection of resistant mutants in 18%.
-
Merck announced on September 30th that it is voluntarily withdrawing rofecoxib (Vioxx) from the worldwide market.
-
Agents which alter cardiac repolarization have been associated with torsades de pointes.
-
The FDA has approved a new formulation of hydromorphone for the management of pain.
-
Adding early manual manipulation of the cervicothoracic spine for shoulder pain or dysfunction disorders, in addition to regular care of information, advice and medications, produced much better recovery at both 12- and 52-weeks post treatments.
-
The relative risk for each 1% increase in hemoglobin A1c was 1.3 for CHD, 1.2 for CVD, and 1.2 for all cause mortality.
-
Current use of gastric acid-suppressive therapy was associated with an increased risk of community-acquired pneumonia.
-
-
Part II of this two-part series focuses on facial nerve palsies and oropharyngeal infections. The authors present a systematic approach to differential diagnosis and identification of etiologic agents responsible for such conditions as peritonsillar abscess, epiglottitis, and pharyngeal infections. Radiographic and bacteriologic findings are emphasized, and appropriate antibiotic therapy is presented. The authors have provided treatment tables that direct emergency practitioners toward outcome-effective therapy.
-
Parts I and II of this series discussed general facial wound repair, forehead and scalp trauma, eye trauma, nasal trauma, and midface fractures. This third and final part of the series covers mandible, mouth, ear, and pediatric trauma.
